Richland WA, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce today that it worked with Mayo Clinic doctors to design and then conduct tests on the ...
The PM-4 and PM-8 programmable 4 and 8-Channel Pressure Injector systems are designed for one to eight channel intracellular injection and extracellular perfusion. These microinjection and perfusion ...
Open label, randomized, phase II study of pertuzumab (P) in patients (pts) with metastatic breast cancer (MBC) with low expression of HER2 No significant financial relationships to disclose. This is ...
Phase 1 trial of 17-AAG in patients with relapsed and refractory multiple myeloma (MM) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results